NICE (National Institute for Clinical Excellence) confirms sixth work programme
This article was originally published in Clinica
Five device-based therapies are to be appraised under the UK National Institute for Clinical Excellence's (NICE) sixth technology appraisal programme. They are: electroconvulsive therapy; insulin pump therapy for people with type-1 diabetes; home-versus-hospital dialysis; tension-free vaginal tape for stress incontinence; and thermal endometrial ablation for menorrhagia.
You may also be interested in...
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake – but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.